Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing policy and health research without systematic review methodology
OpenAlex W3025423907 · doi:10.1002/wps.20735
What was done
This narrative review synthesized US research on the public health impacts of legalizing adult recreational cannabis use. It evaluated effects on cannabis market dynamics (price, availability, potency), consumption patterns across adults and adolescents, adverse health events (emergency department visits, hospitalizations), and regulatory policy options aimed at limiting harms.
What was found
The abstract reports directional outcomes without quantitative data. Legalization substantially reduced cannabis prices, increased product potency, and expanded availability to adults. It appeared to increase the frequency of cannabis use among adults, but no increase was observed among youth. In addition, emergency department attendances and hospitalizations for select cannabis-related harms increased.
Why it matters
This paper summarizes early post-legalization public health data in the US, highlighting trade-offs between increased adult access/market changes and rising acute healthcare encounters.
Limits
The abstract provides no quantitative effect sizes, statistical tests, or participant counts. As a narrative review, it lacks formal systematic search and appraisal criteria, and observations reflect an early regulatory period constrained by federal prohibition.
Cited by
- supports Following cannabis legalization, cannabis use among youth has changed only slightly, with the main growth in use occurring among adults.